Hard-working, passionate staff...Terrible Leadership - Anonymous employee T1D Exchange Employee Review

1.0
Jan 5, 2017
Anonymous employee
Recommend
CEO approval
Business outlook

Pros

Mission-based work focused on helping the type 1 diabetes patients and families. Ability to work independently without micromanagement. Good teamwork on the individual program level.

Cons

"Senior Leadership Team" has all the power and perks, but slows down projects by being unresponsive. inconsistent, and by changing the goals on a regular basis. CEO has no personal connection to the disease and seems more interested in making his mark as an individual, even though he has a talented and passionate team doing all the hard work. Very inconsistent employee perks, no career path, little recognition of existing employees, therefore there is a very high turnover rate. Senior Leadership is aware of this, but they don't care. Always focused on bringing in new employees, no interest in retaining staff who knows the community and cares about the mission. Extremely frustrating place to work.

Explore other reviews about T1D Exchange

5.0
Apr 10, 2024
Recommend
CEO approval
Business outlook

Pros

Smart and dedicated team with a focus on improving diabetes outcomes.

Cons

Can be difficult working with multiple clinics in the collaborative.

2.0
Oct 6, 2024
Recommend
CEO approval
Business outlook

Pros

Salary and decent benefits. Remote work. Quality improvement team is doing some important work.

Cons

Organization harvests data from people with T1D via their registry. While the patient users of this registry may think that their data is going to diabetes research for a cure, in fact it's just going to pharma. Pharma uses this information with the sole goal of improving their bottom line. The CEO of the org makes close to half a mil annually leading a small (under $10 million in annual revenue) nonprofit, which seems awfully high for a person who had no experience leading a charity when he began. I wonder about this place. They get nearly all of their money from pharma selling data and research support. It's lucrative and would seem more appropriate for a for-profit as pharma is their client, not the patient with T1D.

See reviews by: Helpful|Rating|Date|All